Stocks in Play

9/25/2020 - 10:41 AM EST - First Majestic Silver Corp. : Announced an update related to the ongoing tax dispute with the Mexican tax authority, the Servicio de Administracion Tributaria in connection with the 2012 Advance Pricing Agreement granted to Primero Empresa Minera, S.A. de C.V., a subsidiary of the Company. As previously announced the Company served the Government of Mexico with a Notice of Intent to Submit a Claim under the provisions of Chapter 11 of North American Free Trade Agreement. The service of this Notice initiated a 90-day process for the Government of Mexico to enter into good faith and amicable negotiations with the Company to resolve the dispute. On August 11, the 90-day process deadline expired without any resolution of the tax dispute. First Majestic Silver Corp. shares T.FR are trading down $0.81 at $12.87.

9/25/2020 - 10:33 AM EST - MediPharm Labs Corp. : Announced it has entered into a new white-label supply agreement with DanCann Pharma A/S. The company will be serviced by both GMP approved facilities, MediPharm Labs Inc. and MediPharm Labs Australia Pty Ltd. This marks MediPharm Labs’ third supply agreement for the export of finished products to Denmark expanding its revenue opportunity in an emerging medicinal cannabis market. MediPharm Labs Corp. shares T.LABS are trading up $0.05 at $0.85.

9/25/2020 - 10:22 AM EST - Revive Therapeutics Ltd. : Provided a corporate update on its psychedelics therapeutics programs specifically as it relates to the Company’s oral thin-film delivery system and clinical studies with psilocybin at the University of Wisconsin-Madison. “We are expanding our product pipeline with a focus on psychedelic therapeutics incorporating our novel oral thin-film delivery technology with psilocybin, in which we have prototypes developed and we will move towards clinical studies with the University of Wisconsin-Madison along with other key industry partners,” said Michael Frank, CEO of Revive. “In addition, we are advancing our Phase I clinical study to evaluate the safety and feasibility of psilocybin in adults with Methamphetamine Use Disorder. Our initiatives in product development and clinical studies gives us a leading position in the psychedelic space.” Revive Therapeutics Ltd. shares C.RVV are trading up 2 percent at $0.26.

9/25/2020 - 10:11 AM EST - TMX Group Limited : Has entered into an agreement to acquire AST Investor Services Inc. (Canada), and its subsidiary AST Trust Company (Canada), a leading provider of transfer agency, corporate trust and related services to Canadian public and private companies from a subsidiary of Armor Holdco, Inc. (Armor), a portfolio company of Pacific Equity Partners (PEP), for $165 million in total consideration, which includes $30 million of cash for regulatory and non-regulatory purposes, subject to customary closing conditions and working capital adjustments. TMX Group Limited shares T.X are trading down $1.87 at $133.42.

9/25/2020 - 10:01 AM EST - Innunoprecise Antibodies Ltd. : And LiteVax BV (Oss, the Netherlands ), today announced that they have initiated pre-clinical vaccine trials against SARS-CoV-2. Vaccine design was based on large sets of data obtained during the analysis of IPA's SARS-CoV-2 therapeutic programs. Using this information, ImmunoPrecise designed data-driven, well-defined SARS-CoV-2 spike protein variant vaccine candidates that were combined with a novel class of synthetic carbohydrate derivatives, designed to act as a vaccine adjuvant, with the final formulations aimed at high efficacy and low adverse effects. Innunoprecise Antibodies Ltd. shares V.IPA are trading up $0.08 at $2.45.

9/25/2020 - 9:57 AM EST - Ventripoint Diagnostics Ltd. : Announced that, subject to TSXV approval, it has engaged San Diego Torrey Hills Capital, Inc., a Rancho Santa Fe, California based investor relations firm, to provide market awareness and investor relations services to the Company in compliance with TSXV policies. Cliff Mastricola is the principal of Torrey Hills Capital and will be responsible for activities related to Ventripoint. Ventripoint Diagnostics Ltd.
shares V.VPT are trading up $0.03 at $0.11.

9/25/2020 - 9:53 AM EST - Aurania Resources Ltd. : Reports that while the scout drilling program at the Tsenken N2 copper target is ongoing, other exploration teams have discovered extensions to the areas of silver enrichment in soil previously reported from the Tiria-Shimpia silver-gold target over a cumulative length of 15 kilometres. Tiria-Shimpia is on the short-list for scout drilling when the program at Tsenken has been completed. Aurania Resources Ltd. shares V.ARU are trading up $0.28 at $4.70.

9/25/2020 - 9:47 AM EST - Cardiol Therapeutics Inc. : Announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application to commence a Phase II/III, double-blind, placebo-controlled clinical trial investigating the efficacy and safety of CardiolRx™, a pharmaceutically produced extra strength cannabidiol formulation, in 422 hospitalized COVID-19 patients with a prior history of, or risk factors for, cardiovascular disease (CVD). The trial will take place at major centers in the United States, where the prevalence of COVID-19 remains high. Cardiol Therapeutics Inc. shares T.CRDL are trading up $0.70 at $3.20.

9/25/2020 - 9:41 AM EST - Calfrac Well Services Ltd. : Says Wilks Brothers, LLC acknowledges the press release by Calfrac yesterday in which it nnounced that it hadamended the Management Transaction. What yesterday's announcement makes crystal clear is that the Board of Calfrac has been forced to concede that the original Management Transaction was fundamentally flawed and undervalued its shareholders' interests in the Company. In effect, the self-selected unsecured creditors and Calfrac insiders who proposed the Management Transaction were attempting to appropriate that value for themselves. Through Wilks' efforts, and at considerable expense, that value has been pried from their grasp and grudgingly conceded to the long-suffering shareholders of Calfrac. This marks only the first step in ensuring that Calfrac's shareholders receive fair value. Calfrac Well Services Ltd.
shares T.CFW are trading unchanged at $0.15.

9/25/2020 - 9:36 AM EST - Corby Spirit and Wine Limited : And Pernod Ricard S.A. announced yesterday after the close of TSX trading the renewal of the representation of Pernod Ricard's brands by Corby in the Canadian market.Pernod Ricard is the global number two player in spirits and wine, with iconic, premium, international brands, including Absolut vodka, Jameson Irish whiskey, The Glenlivet single malt Scotch whisky, Beefeater, Monkey 47 and Malfy gins, Malibu rum, Kahlúa liqueur, Ballantine's and Chivas Regal blended Scotch whiskies and Jacob's Creek, Stoneleigh and Campo Viejo wines. Corby Spirit and Wine Limited shares T.CSW.A are trading unchanged at $15.05.